Zacks Bull and Bear of the Day Highlights: Vodafone, Somaxon, McDonald’s Corporation, Starbucks and Yum! Brands Inc. – Press Releases
Source: http://www.zacks.com/stock/news/20876/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+Vodafone%2C+Somaxon%2C+McDonald%27s+Corporation%2C+Starbucks+and+Yum%21+Brands+Inc.+-+Press+ReleasesPosted on Tuesday, June 9th, 2009 | In Market Commentary, Stocks to Watch
For Immediate Release
Chicago, IL – June 9, 2009 – Zacks Equity Research highlights Vodafone (VOD) as the Bull of the Day and Somaxon (SOMX) the Bear of the Day. In addition, Zacks Equity Research provides analysis on McDonald’s Corporation (MCD), Starbucks (SBUX) and Yum! Brands Inc (YUM).
Full analysis of all these stocks is available at http://at.zacks.com/?id=2676.
Here is a synopsis of all five stocks:
Bull of the Day:
We maintain our Buy recommendation for Vodafone (VOD), the largest revenue-generating international wireless carrier. Operating results for fiscal 2009 were highlighted by respectable increases in subscriber count bolstered by record net additions for its Indian operation.
Vodafone continues to accelerate 3G wireless service deployments and expanding network availability across Asia, Eastern Europe and Africa, primarily through acquisitions. Additionally, the company is focused on improving shareholder returns through increased dividend payouts, which supports our valuation forecasts.
Management’s outlook for fiscal 2010 appears favorable as operating results are expected to improve with continued growth across incipient markets coupled with ongoing cost saving initiatives and currency exchange translation gains.
Bear of the Day:
On June 4, 2009, Somaxon (SOMX) announced that is has resubmitted the new drug application (NDA) to the U.S. FDA for Silenor (doxepin) for the treatment of insomnia. Despite this good news, we struggle to see how this drug can capture enough of the insomnia market to drive Somaxon to strong profitability.
The insomnia market is dominated by generic molecules, and without an onset claim, Silenor will already lose out on approximately half the market. Plus, Somaxon is running dangerously low on cash. We estimate the current cash balance is only enough to fund operations until July 2009.
Therefore, we expect a highly dilutive (30-40%) capital raise in the next week or two. We have a Sell rating on the shares and a target price of $0.50.
Latest Posts on the Zacks Analyst Blog:
MCD Sizzles, But FX to Take a Bite
McDonald’s Corporation (MCD) continues to report strong worldwide same-store sales but, as expected, foreign currency translation remains a drag on earnings.
Much of the foreign exchange [FX] drag — expected to be $0.20 for 2009 — was already factored into estimates or offset by anticipated declines in commodity costs in 2H09. In turn, we are trimming our 2009 EPS estimates by just $0.04 to $3.78 and maintaining our Buy rating on what we consider a defensive safe haven in a dangerous market.
McDonald’s announced today that global same-restaurant sales jumped 5.1% in May, with overseas operations remaining strong and those in the U.S. moderating. Comps in in the U.S. grew 2.8% in May — respectable given the powerful 7.7% rise in May 2008, though slower than the 6.1% reported in April. In Europe, comps surged 7.6%, and in Asia/Pacific, Middle East and Africa they grew 6.4%.
McDonald’s U.S. sales were fueled by its successful recent rollout of McCafe coffees. The new premium coffee line has an appealing ad campaign and is likely to draw value-conscious customers away from the $4 lattes at Starbucks (SBUX).
Europe benefited as restaurants added breakfast and extended their late night hours. Notably, Germany — a very weak area for Burger King — continued to post positive comps.
Strong sales in Australia and Japan juiced strong Asia/Pacific comps. McDonald’s has successfully tailored its menu offerings to local tastes.
China, where McDonald’s represents a more expensive meal, remains one area of weakness. China’s contraction, however, should have a much bigger effect on Yum! Brands Inc (YUM), which derives 28% of its revenue there.
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks “Profit from the Pros” e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2677.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks InvestmentResearch is through our free daily email newsletter; Profit from the Pros. In short, it’s your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4582.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
Last 5 posts by Zacks Market Commentaries
- Settlement in Xerox-ACS Merger - Analyst Blog - November 24th, 2009
- Citi Expects Strong Economic Growth - Analyst Blog - November 24th, 2009
- Downgrading Expedia to Neutral - Analyst Blog - November 24th, 2009
- Foot Locker Misses Expectations - Analyst Blog - November 24th, 2009
- Patni Exceeds Estimates - Analyst Blog - November 24th, 2009
3g, 3G wireless service deployments;, Africa, Asia, Australia, Blog, Brands Inc., Burger King, Chicago, China, Eastern Europe, Europe, Fda, Germany, insomnia, Japan, Leonard Zacks;, Market Commentary, McDonald's Corporation, McDonald's U.S.;, Middle East, revenue generating international wireless carrier;, Somaxon;, Starbucks, Stocks to Watch, treatment of insomnia, United States, USD, Vodafone, Yum, Zacks Equity Research, Zacks Investment Research Inc.;, Zacks Market Commentaries
![]() About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |



